Kourie, H. R., El Rassy, E., Clatot, F., de Azambuja, E., & Lambertini, M. (2017). Emerging treatments for HER2-positive early-stage breast cancer: Focus on neratinib. Onco Targets Ther.

Kourie, Hampig Raphael, Elie El Rassy, Florian Clatot, Evandro de Azambuja, et Matteo Lambertini. "Emerging Treatments for HER2-positive Early-stage Breast Cancer: Focus On Neratinib." Onco Targets Ther 2017.

Kourie, Hampig Raphael, et al. "Emerging Treatments for HER2-positive Early-stage Breast Cancer: Focus On Neratinib." Onco Targets Ther 2017.